Focused genomic studies examining specific ‘hotspot’ DNA mutations identified recurrent KRAS mutations.[4] A recent whole exome sequencing effort to characterize cancers afflicting adolescents and young adults included one patient with urachal carcinoma and also identified an activating KRAS mutation. This evidence concerns the gene KRAS and cancer.